MAP3K6 Mutations in a Neurovascular Disease Causing Stroke, Cognitive Impairment, and Tremor

Abstract

ObjectiveTo describe a possible novel genetic mechanism for cerebral small vessel disease (cSVD) and stroke.MethodsWe studied a Swedish kindred with ischemic stroke and intracerebral hemorrhage, tremor, dysautonomia, and mild cognitive decline. Members were examined clinically, radiologically, and by histopathology. Genetic workup included whole-exome sequencing (WES) and whole-genome sequencing (WGS) and intrafamilial cosegregation analyses.ResultsFifteen family members were examined clinically. Twelve affected individuals had white matter hyperintensities and 1 or more of (1) stroke episodes, (2) clinically silent lacunar ischemic lesions, and (3) cognitive dysfunction. All affected individuals had tremor and/or atactic gait disturbance. Mild symmetric basal ganglia calcifications were seen in 3 affected members. Postmortem examination of 1 affected member showed pathologic alterations in both small and large arteries the brain. Skin biopsies of 3 affected members showed extracellular amorphous deposits within the subepidermal zone, which may represent degenerated arterioles. WES or WGS did not reveal any potentially disease-causing variants in known genes for cSVDs or idiopathic basal ganglia calcification, but identified 1 heterozygous variant, NM_004672.4 MAP3K6 c.322G>A p.(Asp108Asn), that cosegregated with the disease in this large family. MAP3K6 has known functions in angiogenesis and affects vascular endothelial growth factor expression, which may be implicated in cerebrovascular disease.ConclusionsOur data strongly suggest the MAP3K6 variant to be causative for this novel disease phenotype, but the absence of functional data and the present lack of additional families with this disease and MAP3K6 mutations still limit the formal evidence for the variant's pathogenicity.

Whole-transcriptome sequencing analysis reveal mechanisms of Yiqi Huoxue Yangyin (YHY) decoction in ameliorating D-gal-induced cardiac aging

“…Pik3r5 encodes the catalytic subunits of PI3K signaling pathway which could control AKT/NO/mTOR, NADPH oxidase, and TGF-b/Smad pathway that are involved in cardiovascular diseases [44,45]. Additionally, Map3k6 constitutes a component of the MAPK pathway, chains of highly conserved serine/threonine protein kinases that communicate signals from cell surface receptors to the nucleus, influencing gene transcription [46]; MAPK signaling pathway participates in aging-induced changes in various organs including brain, liver, and heart [47]. The above two pathways, PI3K and MAPK signaling pathway, were both found to be regulated by miR-770, which is consistent with ceRNA network results in our study [48][49][50].…”

Epigenome-wide association study of lung function in Latino children and youth with asthma

“…Reduced expression of MAP3K6 downregulates VEGF , which alters normal angiogenesis [ 35 ]. Moreover, MAP3K6 participates in cell signaling and subsequent regulation of gene expression [ 36 ].…”

MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types

“…Existing literature demonstrate that MAP3K6 is inhibited by CDK5 to regulate melanin production in mice [60]. Furthermore, MAP3K6 mutations are associated with cerebral small ves-sel disease (cSVD) causing stroke, cognitive impairment, and tremor, as well as the development of gastric cancer [61,62]. Along with MAP3K5, MAP3K6 also known as ASK2, is a member of ASK family [49].…”